En esta página
01OLMA precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
OLMA Olema Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$8,23
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$6,65mínimo 52 semanas
$36,26máximo 52 semanas
Capitalización Bursátil (MRQ)
$719M
P/E
-4.4
BPA
$-1.87
tus insignias
Rango 52S
$7–$36
Calificación del Analista
BUY
Precio Objetivo
$36
P/E
-4.4
ROE
-39.4%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
OLMA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$8.22
Capitalización Bursátil (MRQ)
$719M
P/E
-4.4
BPA
$-1.87
ROE
-39.4%
Rango 52S
$7–$36
OLMA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-1.872019-12-31 → 2025-12-31
Flujo de caja libre·2021-12-31 → 2024-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | OLMA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.4promedio 5A ≈-5.7 | ≈-5.7 | · | · | |
| P/C (MRQ) | 1.7promedio 5A ≈2.0 | ≈2.0 | 3.5 | Infravalorado | |
| Price / Cash Flow (Precio / Flujo de Caja) | -4.6promedio 5A ≈-7.2 | ≈-7.2 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.4promedio 5A ≈2.0 | ≈2.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | OLMA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -33.0%promedio 5A ≈-34.2% | ≈-34.2% | -33.0% | En línea | |
| ROE | -39.4%promedio 5A ≈-38.7% | ≈-38.7% | -39.4% | En línea | |
| ROIC | -37.3% | · | -68.5% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | OLMA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 8.9promedio 5A ≈15.5 | ≈15.5 | 8.4 | En línea | |
| Quick Ratio (Ratio Rápido) | 9.8promedio 5A ≈15.3 | ≈15.3 | 5.4 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.08%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 11, 2026 | $-0.61 | $-0.56 | -9.8% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.52 | $-0.54 | 3.6% |
| 31 de diciembre de 2025 | $-0.50 | $-0.54 | 7.3% | |
| 30 de septiembre de 2025 | $-0.49 | $-0.49 | 0.67% | |
| 30 de junio de 2025 | $-0.51 | $-0.38 | -33.0% | |
| 31 de marzo de 2025 | $-0.36 | $-0.52 | 30.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $158M | $125M | $86M | $82M | $51M | $14M | |
| SG&A Expense | $21M | $18M | $19M | $25M | $20M | $8M | |
| Operating Expenses | $179M | $142M | $105M | $107M | $71M | $22M | |
| Operating Income | $-179M | $-142M | $-105M | $-107M | $-71M | $-22M | |
| Interest Expense | · | · | · | · | · | $653.0K | |
| Interest Income | $16M | $13M | $8M | $2M | $442.0K | $60.0K | |
| Other Non-op | $23.0K | $102.0K | $-19.0K | $-27.0K | $-47.0K | · | |
| Pretax Income | $-162M | $-129M | · | · | · | · | |
| Income Tax | $3.0K | $2.0K | $2.0K | $1.0K | · | · | |
| Net Income | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| EPS (Basic) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| EPS (Diluted) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| Shares (Basic) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| Shares (Diluted) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| EBITDA | $-178M | $-142M | $-105M | $-107M | $-71M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $139M | $69M | $24M | $14M | $339M | |
| Short-term Investments | $457M | $295M | $193M | $181M | $273M | · | |
| Prepaid Expense | $10M | $4M | $5M | $4M | $3M | $4M | |
| Current Assets | $515M | $438M | $267M | $209M | $291M | $342M | |
| PP&E (Net) | $274.0K | $746.0K | $968.0K | $1M | $1M | $75.0K | |
| PP&E (Gross) | · | · | · | $2M | $2M | $137.0K | |
| Accum. Depreciation | · | · | · | $581.0K | $224.0K | $62.0K | |
| Other Non-current Assets | · | $15.0K | · | $3M | $540.0K | $510.0K | |
| Total Assets | $533M | $451M | $277M | $216M | $296M | $343M | |
| Accounts Payable | $9M | $4M | $3M | $374.0K | $23.0K | $719.0K | |
| Current Liabilities | $52M | $42M | $22M | $17M | $9M | $5M | |
| Capital Leases | $69.0K | $257.0K | $1M | $2M | $2M | · | |
| Total Liabilities | $55M | $42M | $23M | $18M | $11M | $5M | |
| Common Stock | $8.0K | $7.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.08B | $844M | $559M | $408M | $389M | $371M | |
| Retained Earnings | $-598M | $-435M | $-306M | $-209M | $-104M | $-33M | |
| AOCI | $621.0K | $143.0K | $347.0K | $-2M | $-149.0K | · | |
| Stockholders' Equity | $479M | $409M | $254M | $198M | $285M | $338M | |
| Liabilities + Equity | $533M | $451M | $277M | $216M | $296M | $343M | |
| Shares Outstanding | 81,376,449 | 74,312,608 | 54,992,784 | 40,287,097 | 39,797,263 | 39,308,238 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $490.0K | $393.0K | $377.0K | $357.0K | $163.0K | $11.0K | |
| Stock-based Comp | $18M | $23M | $17M | $19M | $16M | $3M | |
| Other Non-cash | $-2M | $2M | $-5M | $4M | $4M | · | |
| Operating Cash Flow | $-147M | $-104M | $-84M | $-82M | $-51M | $-20M | |
| CapEx | · | $159.0K | · | $363.0K | $2M | $56.0K | |
| Investing Cash Flow | $-156M | $-94M | $-5M | $91M | $-275M | $-56.0K | |
| Financing Cash Flow | $211M | $269M | $133M | $476.0K | $1M | $358M | |
| Net Change in Cash | $-91M | $71M | $45M | $10M | $-325M | $338M | |
| Free Cash Flow | · | $-105M | · | $-82M | $-52M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -33.0% | -35.6% | -39.2% | -41.0% | -22.3% | · | |
| ROE | -39.4% | -42.6% | -36.5% | -50.5% | -24.3% | · | |
| ROIC | -37.3% | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 | · | |
| Quick Ratio | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | $5.50 | $4.62 | $4.90 | $7.15 | · | |
| Cash Flow / Share | $-1.69 | $-1.78 | $-1.85 | $-2.05 | $-1.28 | · | |
| Cash / Share | $0.59 | $1.88 | $1.25 | $0.59 | $0.35 | · | |
| EPS (TTM) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| Market Cap | $2.03B | $433M | $772M | $99M | $373M | · | |
| P/E | -13.4 | -2.6 | -6.6 | -0.9 | -5.2 | -14.1 | |
| P/B | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Tangible Book | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Cash Flow | -13.9 | -4.2 | -9.2 | -1.2 | -7.3 | · | |
| P / FCF | · | -4.1 | · | -1.2 | -7.1 | · | |
| Earnings Yield | -7.5% | -37.7% | -15.2% | -106.9% | -19.2% | -7.1% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $58M | $49M | $43M | $40M | $44M | $31M | $32M | $33M | $29M | $30M | $26M | $19M | $18M | $23M | $22M | $18M | |
| SG&A Expense | $9M | $9M | $7M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $7M | $6M | $6M | |
| Operating Expenses | $67M | $58M | $50M | $46M | $48M | $35M | $37M | $38M | $34M | $34M | $30M | $23M | $22M | $30M | $27M | $23M | |
| Operating Income | $-67M | $-58M | $-50M | $-46M | $-48M | $-35M | $-37M | $-38M | $-34M | $-34M | $-30M | $-23M | $-22M | $-30M | $-27M | $-23M | |
| Interest Income | $5M | $5M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $1M | $973.0K | $622.0K | |
| Other Non-op | $-528.0K | $121.0K | $13.0K | $12.0K | $38.0K | $-40.0K | $-93.0K | $138.0K | $40.0K | $17.0K | $93.0K | $-79.0K | $-44.0K | $11.0K | $67.0K | $-120.0K | |
| Net Income | $-63M | $-53M | $-46M | $-42M | $-44M | $-30M | $-34M | $-35M | $-30M | $-31M | $-27M | $-22M | $-20M | $-28M | $-26M | $-23M | |
| EPS (Basic) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| EPS (Diluted) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| Shares (Basic) | 104,453,732 | 102,800,098 | · | 85,732,221 | 85,497,426 | 85,426,223 | · | 57,262,803 | 56,282,402 | 55,574,324 | · | 44,977,161 | 40,720,294 | 40,354,493 | · | 40,036,201 | |
| Shares (Diluted) | 104,453,732 | 102,800,098 | · | 85,732,221 | 85,497,426 | 85,426,223 | · | 57,262,803 | 56,282,402 | 55,574,324 | · | 44,977,161 | 40,720,294 | 40,354,493 | · | 40,036,201 | |
| EBITDA | $-67M | $-58M | · | $-46M | $-48M | $-35M | · | $-38M | $-34M | $-34M | · | $-23M | $-22M | $-30M | · | $-23M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $53M | $48M | $35M | $52M | $51M | $139M | $36M | $17M | $34M | $69M | $117M | $35M | $41M | $24M | $27M | |
| Short-term Investments | $412M | $453M | $457M | $294M | $309M | $342M | $295M | $179M | $222M | $215M | $193M | $159M | $132M | $145M | $181M | $196M | |
| Prepaid Expense | $9M | $8M | $10M | $5M | $6M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $4M | $3M | $4M | $2M | |
| Current Assets | $470M | $513M | $515M | $334M | $368M | $397M | $438M | $218M | $242M | $252M | $267M | $282M | $172M | $189M | $209M | $225M | |
| PP&E (Net) | $382.0K | $356.0K | $274.0K | $486.0K | $560.0K | $653.0K | $746.0K | $849.0K | $945.0K | $1M | $968.0K | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $698.0K | $744.0K | $681.0K | · | $484.0K | |
| Other Non-current Assets | · | · | · | · | $15.0K | $14.0K | $15.0K | $15.0K | $16.0K | · | · | · | · | $3M | · | $3M | |
| Total Assets | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Accounts Payable | $2M | $4M | $9M | $3M | $934.0K | $151.0K | $4M | $3M | $4M | $8M | $3M | $2M | $2M | $681.0K | $374.0K | $14.0K | |
| Current Liabilities | $53M | $47M | $52M | $42M | $33M | $26M | $42M | $31M | $27M | $26M | $22M | $16M | $15M | $19M | $17M | $13M | |
| Capital Leases | $0 | $0 | $69.0K | $310.0K | $602.0K | $123.0K | $257.0K | $562.0K | $859.0K | $1M | $1M | $2M | $1M | $1M | $2M | $2M | |
| Total Liabilities | $56M | $50M | $55M | $45M | $37M | $26M | $42M | $31M | $27M | $27M | $23M | $18M | $16M | $21M | $18M | $14M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.15B | $1.13B | $1.08B | $858M | $854M | $849M | $844M | $600M | $594M | $573M | $559M | $554M | $419M | $413M | $408M | $403M | |
| Retained Earnings | $-714M | $-651M | $-598M | $-551M | $-509M | $-465M | $-435M | $-402M | $-367M | $-337M | $-306M | $-279M | $-257M | $-237M | $-209M | $-183M | |
| AOCI | $-947.0K | $-460.0K | $621.0K | $526.0K | $314.0K | $420.0K | $143.0K | $464.0K | $-118.0K | $-10.0K | $347.0K | $-241.0K | $-518.0K | $-978.0K | $-2M | $-3M | |
| Stockholders' Equity | $431M | $480M | $479M | $307M | $345M | $383M | $409M | $199M | $227M | $236M | $254M | $275M | $162M | $175M | $198M | $218M | |
| Liabilities + Equity | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Shares Outstanding | 87,452,166 | 87,332,971 | 81,376,449 | 68,652,730 | 68,627,886 | 68,333,065 | 74,312,608 | 57,288,319 | 57,246,411 | 55,867,863 | 54,992,784 | 54,601,516 | 41,122,482 | 40,438,320 | 40,287,097 | 40,084,568 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102.0K | $119.0K | $187.0K | $43.0K | $132.0K | $128.0K | $116.0K | $95.0K | $94.0K | $88.0K | $88.0K | $90.0K | $99.0K | $100.0K | $97.0K | $91.0K | |
| Stock-based Comp | $13M | $10M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $5M | $5M | $4M | |
| Other Non-cash | · | $-3M | · | · | · | $-18M | · | · | · | $2M | · | · | · | $3M | · | · | |
| Operating Cash Flow | $-46M | $-46M | $-38M | $-35M | $-30M | $-44M | $-26M | $-27M | $-28M | $-23M | $-18M | $-23M | $-22M | $-20M | $-20M | $-18M | |
| CapEx | · | · | · | $0 | · | · | $0 | $0 | $6.0K | $153.0K | · | · | · | · | $173.0K | $139.0K | |
| Investing Cash Flow | $41M | $5M | $-162M | $17M | $34M | $-45M | $-114M | $46M | $-5M | $-20M | $-31M | $-25M | $14M | $37M | $16M | $20M | |
| Financing Cash Flow | $1M | $46M | $214M | $41.0K | $-3M | $222.0K | $244M | $92.0K | $16M | $9M | $523.0K | $131M | $2M | $220.0K | $273.0K | $106.0K | |
| Net Change in Cash | $-4M | $4M | $13M | $-17M | $2M | $-89M | $104M | $19M | $-17M | $-35M | $-49M | $82M | $-6M | $17M | $-3M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-24M | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.5% | -11.3% | · | -14.5% | -13.8% | -9.0% | · | -13.2% | -14.1% | -13.5% | · | -8.2% | -9.4% | -12.0% | · | -8.4% | |
| ROE | -16.3% | -12.3% | · | -16.7% | -15.3% | -9.8% | · | -14.6% | -15.6% | -15.1% | · | -8.7% | -10.1% | -12.9% | · | -8.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 10.9 | · | 8.0 | 11.1 | 15.2 | · | 7.1 | 9.1 | 9.6 | · | 17.7 | 11.6 | 9.8 | · | 17.9 | |
| Quick Ratio | 8.7 | 10.7 | · | 7.9 | 10.9 | 15.1 | · | 7.0 | 9.0 | 9.5 | · | 17.3 | 11.3 | 9.6 | · | 17.7 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.92 | $5.50 | · | $4.48 | $5.03 | $5.61 | · | $3.47 | $3.97 | $4.23 | · | $5.04 | $3.93 | $4.33 | · | $5.43 | |
| Cash Flow / Share | · | $-0.45 | · | · | · | $-0.51 | · | · | · | $-0.42 | · | · | · | $-0.51 | · | · | |
| Cash / Share | $0.56 | $0.60 | · | $0.51 | $0.76 | $0.74 | · | $0.63 | $0.30 | $0.60 | · | $2.15 | $0.85 | $1.01 | · | $0.67 | |
| EPS (TTM) | $-2.13 | $-2.03 | · | $-1.86 | $-1.97 | $-2.00 | · | $-2.17 | $-2.05 | $-2.00 | · | $-2.32 | $-2.41 | $-2.74 | · | $-2.51 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-205M | $-185M | · | $-150M | $-142M | $-129M | · | $-123M | $-110M | $-99M | · | $-96M | $-97M | $-110M | · | $-100M | |
| Market Cap | $1.09B | $1.30B | · | $672M | $292M | $257M | · | $684M | $619M | $632M | · | $674M | $371M | $140M | · | $111M | |
| P/E | -5.9 | -7.3 | · | -5.3 | -2.2 | -1.9 | · | -5.5 | -5.3 | -5.7 | · | -5.3 | -3.7 | -1.3 | · | -1.1 | |
| P/B | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Tangible Book | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Cash Flow | · | -28.3 | · | · | · | -5.8 | · | · | · | -26.9 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -17.0% | -13.6% | · | -19.0% | -46.2% | -53.2% | · | -18.2% | -18.9% | -17.7% | · | -18.8% | -26.7% | -79.0% | · | -90.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-162M | $-129M | $-97M | $-105M | $-71M |
| EPS Diluido | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 |
| Ratio Rápido | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-105M | · | $-82M | $-52M |
Propietarios institucionales (13F) 199 declarantes · $1.4B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
199
Valor en tenencia
$1.4B
Nuevas posiciones
25
Posiciones cerradas
37
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 25 (-33 vs trimestre anterior) | 37 (-10 vs trimestre anterior) | 72 (-4 vs trimestre anterior) | 68 (+15 vs trimestre anterior) | -8.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $151 909 702 | 12 143 062 | 11,15% | Acciones |
| Paradigm Biocapital Advisors LP | $108 468 906 | 8 670 576 | 7,96% | Acciones |
| JANUS HENDERSON GROUP PLC | $106 013 431 | 7 108 488 | 7,78% | Acciones |
| VANGUARD GROUP INC | $89 033 875 | 3 561 355 | 6,53% | Acciones |
| Bain Capital Life Sciences Investors, LLC | $88 636 465 | 7 085 249 | 6,50% | Acciones |
| BlackRock, Inc. | $84 000 783 | 6 714 691 | 6,16% | Acciones |
| BVF INC/IL | $66 251 621 | 5 295 893 | 4,86% | Acciones |
| Siren, L.L.C. | $60 760 432 | 4 856 949 | 4,46% | Acciones |
| STATE STREET CORP | $53 993 886 | 4 316 058 | 3,96% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $41 798 625 | 3 341 217 | 3,07% | Acciones |
| Logos Global Management LP | $40 143 026 | 3 208 875 | 2,95% | Acciones |
| FRANKLIN RESOURCES INC | $29 393 321 | 2 349 586 | 2,16% | Acciones |
| Cormorant Asset Management, LP | $26 896 500 | 2 150 000 | 1,97% | Acciones |
| MORGAN STANLEY | $22 921 685 | 1 832 269 | 1,68% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $22 759 853 | 1 819 029 | 1,67% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20 806 857 | 1 663 218 | 1,53% | Acciones |
| GOLDMAN SACHS GROUP INC | $19 615 417 | 1 567 979 | 1,44% | Acciones |
| Deep Track Capital, LP | $18 765 000 | 1 500 000 | 1,38% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $17 718 405 | 1 416 533 | 1,30% | Acciones |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | $16 954 790 | 1 355 299 | 1,24% | Acciones |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $15 012 000 | 1 200 000 | 1,10% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $14 154 239 | 1 131 434 | 1,04% | Acciones |
| Point72 Asset Management, L.P. | $13 397 572 | 1 070 949 | 0,98% | Acciones |
| Defilade Capital Management, L.P. | $11 568 723 | 924 758 | 0,85% | Acciones |
| AMERIPRISE FINANCIAL INC | $10 516 481 | 840 646 | 0,77% | Acciones |
| Woodline Partners LP | $9 395 385 | 751 030 | 0,69% | Acciones |
| Candriam S.C.A. | $9 387 633 | 751 133 | 0,69% | Acciones |
| NORTHERN TRUST CORP | $8 443 561 | 674 945 | 0,62% | Acciones |
| Vivo Capital, LLC | $8 404 756 | 671 843 | 0,62% | Acciones |
| Qube Research & Technologies Ltd | $8 298 121 | 663 319 | 0,61% | Acciones |
| CITADEL ADVISORS LLC | $8 029 268 | 641 828 | 0,59% | Acciones |
| Squarepoint Ops LLC | $7 699 530 | 615 470 | 0,56% | Acciones |
| READYSTATE ASSET MANAGEMENT LP | $7 428 801 | 593 829 | 0,55% | Acciones |
| Jones Hill Capital LP | $7 182 817 | 574 166 | 0,53% | Acciones |
| Hudson Bay Capital Management LP | $7 085 664 | 566 400 | 0,52% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $6 585 839 | 526 446 | 0,48% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6 484 458 | 518 342 | 0,48% | Acciones |
| Vestal Point Capital, LP | $5 236 073 | 418 551 | 0,38% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $5 192 338 | 415 055 | 0,38% | Acciones |
| Ikarian Capital, LLC | $4 794 845 | 383 281 | 0,35% | Acciones |
| SEB Asset Management AB | $4 246 649 | 339 461 | 0,31% | Acciones |
| BANK OF AMERICA CORP /DE/ | $4 189 287 | 334 875 | 0,31% | Acciones |
| Fisher Asset Management, LLC | $3 712 015 | 296 724 | 0,27% | Acciones |
| Rock Springs Capital Management LP | $2 942 077 | 235 178 | 0,22% | Acciones |
| UBS Group AG | $2 788 141 | 222 873 | 0,20% | Acciones |
| Bank of New York Mellon Corp | $2 779 441 | 222 177 | 0,20% | Acciones |
| Pier Capital, LLC | $2 760 944 | 220 699 | 0,20% | Acciones |
| Ikarian Capital, LLC | $2 502 000 | 200 000 | 0,18% | Opción de compra |
| Birchview Capital, LP | $2 489 490 | 199 000 | 0,18% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 280 573 | 182 300 | 0,17% | Opción de venta |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities GP LLC, Logos GP LLC ×4 presentaciones | 13 de mayo de 2025 | 4,70% | Enmienda | Inversión pasiva | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×4 presentaciones | 4 de diciembre de 2024 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 22 insiders · 10 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Sean Bohen | PRESIDENT AND CEO | 2 de febrero de 2026 A | 237 650 | 0 | 0 | $0 |
| Jason O'Byrne | CHIEF FINANCIAL OFFICER | 1 de septiembre de 2026 A | · | 0 | 0 | $0 |
| Shawnte Mitchell | CHIEF LEGAL OFFICER | 4 de marzo de 2026 M | 0 | 0 | 3 | $-951 503 |
| Sasha Lu Austin | VP of Finance and Controller | 2 de febrero de 2026 A | 16 188 | 0 | 0 | $0 |
| Naseem Zojwalla | CHIEF MEDICAL OFFICER | 2 de febrero de 2026 A | 4 488 | 0 | 4 | $-7 530 148 |
| David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | 2 de febrero de 2026 A | 542 761 | 0 | 8 | $-4 660 773 |
| Shane William Charles Kovacs | CH. OPERATING & FINANCIAL OFF. | 15 de enero de 2026 S | 139 727 | 0 | 2 | $-2 980 054 |
| Kinney Horn | Chief Business Officer | 1 de febrero de 2023 A | 2 458 | 0 | 0 | $0 |
| John B Moriarty | EVP, Ch. Legal Officer & Sec. | 1 de febrero de 2023 A | · | 0 | 0 | $0 |
| Peter J. Kushner | CHIEF SCIENTIFIC OFFICER | 1 de febrero de 2022 A | 1 431 672 | 0 | 0 | $0 |
| Cyrus Harmon | Consejero | 24 de julio de 2026 S | 702 770 | 0 | 5 | $-743 720 |
| Prakash Raman | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Hrustanovic Gorjan | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Yi Larson | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Graham Walmsley | Consejero | 18 de junio de 2026 A | 700 761 | 0 | 0 | $0 |
| Sandra Horning | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Scott J. Garland | Consejero | 18 de junio de 2026 A | · | 0 | 0 | $0 |
| Ian T Clark | Consejero | 18 de junio de 2026 A | 0 | 0 | 3 | $-7 873 109 |
| Cynthia M Butitta | Consejero | 18 de junio de 2026 A | 83 876 | 0 | 0 | $0 |
| Andrew Rappaport | Consejero | 18 de junio de 2026 A | 0 | 0 | 0 | $0 |
| Frank Mccormick | Consejero | 23 de noviembre de 2020 C | 84 260 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 23 de noviembre de 2020 C | 1 725 406 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 33 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 31 490 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,21% | 92 322 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,20% | 265 667 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 180 516 SH | 19 de agosto de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,06% | 1 261 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,06% | 541 502 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 56 779 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 6 145 SH | 2 de octubre de 2026 | Diario |
| FFSM · FIDELITY COVINGTON TRUST | 0,03% | 41 085 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 451 269 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,03% | 37 461 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 2 009 029 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 69 692 SH | 2 de octubre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,02% | 233 776 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 652 061 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14 261 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 157 394 SH | 19 de agosto de 2026 | Diario |
| ISCG · iShares Trust | 0,01% | 8 630 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 124 208 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 24 851 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 186 331 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 955 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2 323 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 8 460 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 21 603 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 79 879 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 17 563 SH | 10 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 16 063 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 611 290 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 103 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 608 966 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 2 951 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 8 558 SH | 11 de septiembre de 2026 | Diario |
OLMA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 18 analistas
COMPRA
Objetivo mediano
$38.00
+362,0%
6 33,3%
Compra fuerte
10 55,6%
Compra
2 11,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
10 analistas · 2026-09-28Objetivo medio $36.50 +343,8%
← Por Debajo de Todos los Objetivos
Precio Actual $8.22
Mín$16.00
Media$36.50
Máx$59.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| OLMA | $2.03B | -13.4 | · | · | -39.4% | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| ACHV | · | -4.0 | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026